"Designing Growth Strategies is in our DNA"

MRSA Testing Market Size, Share and Global Trend By Test Type (Molecular Diagnostic Tests, Immunodiagnostic Tests), By End User (Hospitals, Diagnostic & Pathology Centers, Research Institutes, Others), and Geography Forecast till 2021-2028

Region : Global | Report ID: FBI100699 | Status : Ongoing

 

KEY MARKET INSIGHTS

The Human body is a host of a variety of microbial flora. One among them is staphylococcus aureus, a gram-positive bacterium, which is most commonly found on the skin as well as in the nasal passage of human. Two major types of MRSA infections are observed, namely, hospital-acquired MRSA infection, and community-acquired MRSA infection. Majority of people are reported to have hospital-acquired MRSA infection due to the lack of hygiene & sanitation in the hospitals.

Growing incidences of MRSA infection globally and an increase in demand for the effective diagnostic techniques for the detection of MRSA infection are likely to upsurge the growth of MRSA testing market during the forecast period. In July 2017, F. Hoffmann-La Roche Ltd announced the launch of Cobas MRSA/SA, a test for detection of MRSA to be used in Cobas Liat System, further augmenting the global MRSA testing market.

To gain extensive insights into the market, Request for Customization


The growth in the global MRSA testing market is driven by increase in prevalence of hospital-acquired MRSA infection and growing developments in molecular-based techniques for the diagnosis of MRSA infection. In addition, growing investments in R&D by many players are likely to boost the growth of MRSA testing market during the forecast period.


However, high sensitivity of primers used during molecular diagnostic test is likely to hamper the growth of the global MRSA testing market during the forecast period.


Key Players Covered


Some of the major companies of the global MRSA testing market are Abbott, Hain Lifescience GmbH, 3M, Alifax Holding S.p.A., Creative Diagnostics, ZeptoMetrix Corporation, Cepheid, Abacus Diagnostica Oy, Diatherix Eurofins, LLC, Puritan Medical Products, Luminex Corporation among others.


SEGMENTATION






















SEGMENTATION



 DETAILS



By Test Type



· Molecular Diagnostic Tests


· Immunodiagnostic Tests



By End User



· Hospitals


· Diagnostic & Pathology Centers


· Research Institutes


· Others



By Geography



· North America (U.S. and Canada)


· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)


· Latin America (Brazil, Mexico, and Rest of Latin America)


· Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)



Growing applications of PCR in detecting mec A gene during MRSA testing and generating fast and accurate results are certain factors likely to anticipate the growth of molecular diagnostic tests during the forecast period.


Key Insights





  • Epidemiology Analysis of MRSA Infections
  • Overview of Technological Advances in MRSA Testing
  • Pricing analysis of MRSA Tests Kits
  • Key Industry Developments-Mergers, Acquisitions and Partnerships

Regional Analysis


The global MRSA testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the market during the forecasting year owing to growing awareness about the MRSA infection and growing developments in diagnostic techniques for MRSA infections. Additionally, growing investments by many key players in the research domain for the development of an effective diagnostic methods are likely to fuel the growth of MRSA testing market during the forecast period. MRSA testing market is likely to upsurge at significant rate in the Asia Pacific region owing to the growing patient population and increase in the demand for the minimally invasive diagnostic methods.


Key Industry Developments




  • In July 2017, F. Hoffmann-La Roche Ltd announced the launch of Cobas MRSA/SA, a test for detection of MRSA to be used in Cobas Liat System.
  • In October 2017, Abbott acquired Alere, as a result Alere became a subsidiary of Abbott and inclusion of all the point of care diagnostic kits and other products into Abbott’s product portfolio.
  • In March 2016, Cepheid announced the commercial launch of Xpert MRSA NxG, a molecular-based diagnostic test for MRSA outside the U.S. market. The assay received CE-IVD status from the European Directive on in-vitro diagnostic medical devices

 


MRSA Testing Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Fresenius
Amgen
Ipsos
Galemed
Jubilant

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X